Skip to main content
. 2014 Mar 7;11(3):2804–2817. doi: 10.3390/ijerph110302804

Table 3.

HRQoL and utility scores in the Patient-MD group by clinical characteristics.

Clinical Characteristics PCS-12 MCS-12 Utility Score
Mean (SD) Median p Mean (SD) Median p Mean (SD) Median p
Main diagnoses (N = 192 *)
Mental and behavioural disorders due to psychoactive substance use 47.2 (10.7) 49.5 0.293 36.7 (11.2) 31.3 0.072 0.673 (0.098) 0.657 0.037
Schizophrenia, schizotypal and delusional disorders 46.4 (9.4) 49.4 42.4 (10.9) 42.7 0.708 (0.121) 0.693
Mood disorders 44.0 (8.9) 43.9 36.8 (12.2) 35.4 0.645 (0.122) 0.626
Anxiety disorders 44.8 (9.6) 45.7 37.8 (13.3) 34.1 0.663 (0.120) 0.629
Other mental and behavioural disorders 44.8 (9.4) 41.4 38.4 (11.3) 36.6 0.697 (0.104) 0.663
Disease severity (N = 177 *)
Mild and moderate (CGI-S scores 2–4) 46.7 (8.3) 48.7 0.256 41.2 (11.8) 41.6 0.120 0.706 (0.128) 0.695 0.044
Severe (CGI-S scores 5–7) 44.8 (9.7) 46.1 38.3 (11.9) 37.0 0.663 (0.112) 0.655
Full-time hospitalization within the previous 12 months (N = 203)
Yes 46.8 (9.2) 48.3 0.045 34.7 (10.8) 33.8 <0.001 0.641 (0.097) 0.626 <0.001
No 44.2 (9.2) 45.8 42.1 (11.6) 42.5 0.701 (0.128) 0.683

* Twelve patients were excluded from this analysis because of missing values on main diagnosis and 26 because of missing values on disease severity score.